This week’s wine news: The Italian Wine Guy notes several disturbing wine trends, plus the Wine Spectator sues another magazine, and Coke wants in the weed business
• Making money: Apparently, I’m not the only one worried about the future of the wine business. The Italian Wine Guy, who spent the last three months visiting retailers and restaurants around the country, writes that price “seems to be one of the biggest factors. It’s the economy, stupid. The wine trade has often been a race to the bottom, and these days, there is a significant concern for revenue and profit.” Consumers, he was told, are showing “high anxiety over a buying decision.” In other words, not everything is peachy-keen in the era of premiumization. And his take on the three-tier system? Intriguing and insightful for someone who used to work for the biggest distributor in the world.
• It’s time for the lawyers: The Wine Spectator is suing a new marijuana magazine called the Weed Spectator for infringing its trademarks and copying its familiar 100-point rating scale for wine to rate cannabis. Reuters reports that the filing says Wine Spectator owner M. Shanken has no interest in associating Wine Spectator and the Wine Spectator marks with cannabis, a largely illegal drug. Any association of this type is likely to tarnish the reputation and goodwill that has been built up in the Wine Spectator marks and business for decades, resulting in dilution of the brand.” I’m most fascinated by the charge the weed magazine is copying the 100-point scoring system. I’d love to watch that unfold in court, given how many people use it and that the Wine Spectator didn’t invent it.
• One more time: Those of us with long memories still laugh about Coca-Cola’s failure in the wine business in the late 1970s. So its foray into marijuana beverages elicits a similar chuckle. Nevertheless, reports the BBC, “the drinks giant is in talks with [Canadian] producer Aurora Cannabis about developing marijuana-infused beverages. These would not aim to intoxicate consumers but to relieve pain.” Apparently, it would be a “recovery drink,” aimed at the same market as Gatorade and Powerade. I’ll leave that straight line alone – it’s almost too easy.